Mr Mrs Miss Ms Dr Other

Dr
Oliver
Chammas

Patent Attorney

London Office

Life sciences

Telephone. +44(0) 207 776 5100
Email. [email protected]
UPC Representative
Our team of specialist European patent litigators, oppositions specialists and patent attorneys bring together an extensive depth of legal and technical knowledge and are qualified to represent you in the UPC.
Vcard
Linkedin

Experience

Oliver is a chartered UK and European Patent Attorney who joined the London Office in September 2020. Oliver has a PhD in Bio-Nanotechnology and a degree in Medical Biochemistry from the University of Leeds. He has a wide range of experience in prosecution, contentious matters, drafting and freedom-to-operate.

Oliver has worked in private practice in IP for four years in both London and Yorkshire with a number of clients ranging from start-ups and universities to multinational companies.

Oliver's main area of focus is nanoscale biotechnology but he has also had experience with technologies such as biologics, medical devices, medical treatments, diagnostic and analytical methods, antibody technology and second medical use inventions for a range of diseases.

Oliver has experience of patent prosecution in the UK and Europe as well as advising clients as to patent prosecution in foreign jurisdictions including the United States, Japan and China.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
Europe

BSC

Medical Biochemistry - University of Leeds

MSC

Integrated PhD & MSc – Molecular Scale Engineering – University of Leeds

PHD

Thesis entitled “Atomic Force Microscopy of DNA-protein Interactions” – University of Leeds

POSTGRADUATE DIPLOMA OR CERTIFICATE

Post-Graduate Certificate in Intellectual Property - Queen Mary University of London

Publications

IP Ingredients: The not so "Impossible" Burger

View publication online

Related News

HGF Ranked #1 in the UK for Trade Mark Portfolios in the 2025 Trade Mark Filing Trends Report by Clarivate.

HGF has achieved the #1 ranking for the UK for trade mark portfolios in the newly released 2025 Trade mark Filing Trends report by Clarivate, recognising the firm as a …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

Post Sale Confusion – dupes and lookalikes beware?

Last month, the UK Supreme Court issued its highly-anticipated decision in Iconix Luxembourg Holdings SARL v Dream Pairs Europe Inc and another [2025] UKSC 25. Helpful background to the dispute …

Read article

A leading case - beware sequence errors in patent claims

Samsung Bioepis UK Ltd v Alexion Pharmaceuticals Inc [2025] EWHC 1240 (Pat) – Mr Justice Meade – 20 May 2025 The UK Patents Court has held that Samsung Bioepis’ and Amgen’s …

Read article

ICELAND left out in the cold by the General Court

Earlier in the month, the EU General Court issued its decision on Iceland Foods Ltd’s appeal of a decision of the Grand Board of Appeal of EUIPO to invalidate an …

Read article

HGF recognised in Managing IP’s New “Trusted Talent” Table in Germany

We are proud to announce that HGF has been ranked in Managing IP’s newly launched Trusted Talent table in Germany, a recognition of our ongoing commitment to excellence in intellectual …

Read article

Briefing Note: UKIPO SEP Consultation

Overview and Strategic Context The UKIPO’s 2025 consultation on Standard Essential Patents (SEPs), announced on 15 July 2025, signals a potential policy shift in how the UK approaches SEP licensing …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us